Results 141 to 150 of about 2,325 (152)

AS1411: Development of an Anticancer Aptamer

2008
Nigel Courtenay-Luck, Donald M. Miller
openaire   +1 more source

Interaction study of Dox-incorporated AS1411 aptamer and nucleolin by molecular dynamics simulation

Molecular Simulation, 2023
Boonchoy Soontornworajit, Yuthana Tantirungrotechai, Pichayanoot Rotkrua   +2 more
exaly  

A novel multifunctional nanoparticles formed by molecular recognition between AS1411 aptamer and redox-responsive paclitaxel-nucleoside analogue prodrug for combination treatment of β-lapachone and paclitaxel

Colloids and Surfaces B: Biointerfaces, 2022
Lingbing Li
exaly  

Tumor targeting with a99mTc-labeled AS1411 aptamer in prostate tumor cells

Journal of Drug Targeting, 2015
Seyed Jalāl Hosseinimehr, Seyed Mohammad Abedi, Majid Piramoon   +2 more
exaly  

A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma

Investigational New Drugs, 2013
Eliezer Van Allen, Toni Choueiri, Jonathan Rosenberg   +2 more
exaly  

AS1411 aptamer-targeted Gold Nanoclusters Effect on the Enhancement of Radiation Therapy Efficacy in Breast tumor-bearing Mice

Nanomedicine, 2018
Amirhosein Kefayat, Masoud Mehrgardi, Daryoush Shahbazi-Gahrouei   +2 more
exaly  

AS1411 aptamer-decorated cisplatin-loaded poly(lactic- co -glycolic acid) Nanoparticles for Targeted Therapy of miR-21-inhibited Ovarian Cancer Cells

Nanomedicine, 2018
Jaleh Barar, Yadollah Omidi, Morteza Eskandani   +2 more
exaly  

Synthesis of AS1411-Aptamer-Conjugated CdTe Quantum Dots with High Fluorescence Strength for Probe Labeling Tumor Cells

Journal of Fluorescence, 2014
Mohammad Ramezani, Mona Alibolandi, Khalil Abnous   +2 more
exaly  

AS1411 aptamer/RGD dual functionalized theranostic chitosan-PLGA nanoparticles for brain cancer treatment and imaging

Biomaterials Advances
Rahul Pratap Singh
exaly  

Improving Chemotherapy Effectiveness: Utilizing CuS Nanoparticles Coated with AS1411 Aptamer and Chitosan for Targeted Delivery of Doxorubicin to Cancerous Cells

Journal of Pharmaceutical Sciences
Mohammad Ramezani, Mona Alibolandi, Khalil Abnous   +2 more
exaly